about
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's candidate, cretostimogene grenaden...
Read More
40.18
0.32
(0.80%)
344.7K
XNAS Volume
XNAS 03 Oct, 2025 3:38 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Cg Oncology Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..